Global Home Global Home  
 
 

 

 

Press Releases

= Add Release to Briefcase

DATE

TITLE

 
Jan 29, 2015 Oculus Innovative Sciences Announces Fiscal Third Quarter 2015 Financial Results and Conference Call PDF 11.0 KB Add to Briefcase
 
 
Jan 26, 2015 Oculus Innovative Sciences Announces Closing of $6.3 Million Underwritten Public Offering PDF 13.4 KB Add to Briefcase
 
 
Jan 21, 2015 Oculus Innovative Sciences Announces Pricing of Upsized $6.3 Million Underwritten Public Offering PDF 13.4 KB Add to Briefcase
 
 
Jan 12, 2015 Oculus Innovative Sciences Enters Into Agreement to Sell Ruthigen, Inc. Shares for $5.5 Million in Event of Ruthigen Merger PDF 12.6 KB Add to Briefcase
 
 
Jan 7, 2015 Oculus Innovative Sciences Announces New Dermatology Division, IntraDerm Pharmaceuticals PDF 16.6 KB Add to Briefcase
 
 
Nov 13, 2014 Oculus Innovative Sciences Reports Financial Results for the Second Quarter of Fiscal Year 2015 PDF 30.2 KB Add to Briefcase
 
 
Nov 11, 2014 Oculus Innovative Sciences Commercializes Microcyn®-Based Solution and Hydrogel for Treatment of Mild-to-Moderate Acne in Europe PDF 15.7 KB Add to Briefcase
 
 
Nov 4, 2014 Oculus Innovative Sciences Receives European CE Mark for New Microcyn®-Based Scar Management Hydrogel PDF 16.2 KB Add to Briefcase
 
 
Oct 30, 2014 Oculus Innovative Sciences Receives European CE Mark for New Microcyn®-Based Atopic Dermatitis Hydrogel PDF 16.2 KB Add to Briefcase
 
 
Oct 30, 2014 Oculus Innovative Sciences Announces Fiscal Second Quarter 2015 Financial Results and Conference Call PDF 11.1 KB Add to Briefcase
 

Showing 1-10 of 271

Page: 1 2 3 ... 28

 Next 10